Predictions
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€4.88
08.08.23
08.08.23
€21.00
08.08.24
08.08.24
176.64%
24.05.24
24.05.24
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€8.24
08.08.23
08.08.23
€12.78
08.08.24
08.08.24
88.77%
24.05.24
24.05.24
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€4.88
08.08.23
08.08.23
€31.98
08.08.24
08.08.24
176.64%
24.05.24
24.05.24
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€5.20
07.08.23
07.08.23
€22.72
07.08.24
07.08.24
176.92%
24.05.24
24.05.24
Precision BioSciences Inc
Start price
Target price
Perf. (%)
€0.48
07.08.23
07.08.23
-
07.08.24
07.08.24
-28.10%
13.02.24
13.02.24
Zivo Bioscience Inc.
Start price
Target price
Perf. (%)
€1.89
07.08.23
07.08.23
€2.40
07.08.24
07.08.24
-29.10%
20.11.23
20.11.23
High Quality Food S.p.a.
Start price
Target price
Perf. (%)
€0.80
07.08.23
07.08.23
€2.00
07.08.24
07.08.24
-10.50%
23.05.24
23.05.24
Beowulf Mining Plc
Start price
Target price
Perf. (%)
€0.012
05.08.23
05.08.23
€0.010
05.08.24
05.08.24
-99.19%
23.05.24
23.05.24
Mullen Automotive Inc.
Start price
Target price
Perf. (%)
€0.11
05.08.23
05.08.23
€0.000
05.08.24
05.08.24
-7.36%
20.11.23
20.11.23
Bad rating
Risky balance sheet
Increased challenges to pay loans and raise capital
Probably not worthwhile Investment
Transmedics Group Inc
Start price
Target price
Perf. (%)
€72.91
04.08.23
04.08.23
€99.72
04.08.24
04.08.24
77.55%
24.05.24
24.05.24
Avast Plc.
Start price
Target price
Perf. (%)
€8.01
03.08.23
03.08.23
€7.00
03.08.24
03.08.24
-
12.09.22
12.09.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Thyssenkrupp Nucera Ag&co.kgaa
Start price
Target price
Perf. (%)
€22.96
01.08.23
01.08.23
-
01.08.24
01.08.24
-51.52%
24.05.24
24.05.24